Stocks were lower at the halfway point Thursday in volatile trading, with the Dow Industrials down more than 1,000 points over two days. The S&P 500 fell more than a percent, while the Nasdaq fared slightly better. The tech-heavy index saw fractional declines a day after a rout in tech stocks marked the worst market drop in eight months. Major tech companies like Microsoft ($MSFT), Facebook ($FB), and Alphabet ($GOOGL) had rebounded from Wednesday's losses with slight gains. The continued sell-off was due in part to concerns about tightening monetary policy. President Trump has broken from tradition and repeatedly criticized the Fed for raising interest rates. He continued to attack Fed Chair Jerome Powell Thursday, saying he was "disappointed" in "far too stringent" rate hike decisions. Earlier in the day, stocks briefly turned positive before extending their losses.

Share:
More In Business
Poll: More Americans think companies benefit from legal immigration
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Tylenol maker rebounds a day after unfounded claims about its safety
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
Load More